Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

A Granulin Variant Causing Childhood Interstitial Lung Disease Responsive to anti-TNF-a Biologic Therapy

ABSTRACT: A Granulin Variant Causing Childhood Interstitial Lung Disease Responsive to anti-TNF-a Biologic Therapy

PROVIDER: PRJNA1140566 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR30004700_1.fastq.gz	Fastqsanger.gz
	SRR30004700_2.fastq.gz	Fastqsanger.gz
	SRR30004701_1.fastq.gz	Fastqsanger.gz
	SRR30004701_2.fastq.gz	Fastqsanger.gz
	SRR30004702_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 96

Similar Datasets

A Granulin Variant Causing Childhood Interstitial Lung Disease Responsive to anti-TNF-a Biologic Therapy

Project description:We combined whole exome sequencing with digital spatial mRNA profiling of clinical lung biopsies in the diagnostic evaluation ofapre-teen with progressive idiopathic fibrotic lung and liver disease refractory to standard therapies. The combined findings of homozygosity for the p.Cys139Arg loss-of-function progranulin (GRN) variant and an alveolar macrophage transcriptomic signature consistent with TNF-alpha pathway activation motivated treatment with anti-TNF monoclonal antibodies, resulting in dramatic improvement of her lung and liver disease. These findings demonstrate the clinical utility of convergent multiomics in the evaluation and treatment of rare disease

2025-02-27 | GSE273182 | GEO

Childhood medulloblastoma

Project description:Childhood medulloblastoma

| PRJNA656544 | ENA

Lung interstitial macrophages

Project description:Lung interstitial macrophages

| PRJNA798739 | ENA

Genetics of Myocardial Interstitial Fibrosis in the Human Heart and Association with Disease

Project description:Myocardial interstitial fibrosis is a common thread in multiple cardiovascular diseases including heart failure, atrial fibrillation, conduction disease and sudden cardiac death. To investigate the biologic pathways that underlie interstitial fibrosis in the human heart, we developed a machine learning model to measure myocardial T1 time, a marker of myocardial interstitial fibrosis, in 41,505 UK Biobank participants. Greater T1 time was associated with diabetes mellitus, renal disease, aortic stenosis, cardiomyopathy, heart failure, atrial fibrillation, conduction disease and rheumatoid arthritis. Mendelian randomization analysis supported a potential causal role for diabetes mellitus type 1 in myocardial interstitial fibrosis. In genome-wide association analysis, we identified 11 independent loci associated with native myocardial T1 time. The identified loci implicated genes involved in glucose transport (SLC2A12), iron homeostasis (HFE, TMPRSS6), tissue repair (ADAMTSL1, VEGFC), oxidative stress (SOD2), cardiac hypertrophy (MYH7B) and calcium signaling (CAMK2D). Transcriptome-wide association studies highlighted the role of expression of ADAMTSL1 and SLC2A12 in human cardiac tissue in modulating myocardial interstitial fibrosis. Using a TGFβ1-mediated cardiac fibroblast activation assay, we found that 9 out of the 11 genome-wide significant loci comprised genes that exhibited temporal changes in expression and/or open chromatin conformation supporting the biological relevance of these loci to myocardial fibrosis and myofibroblast cell state acquisition. Harnessing machine learning to perform large-scale phenotyping of interstitial fibrosis in the human heart, our results yield novel insights into biologically relevant pathways to myocardial fibrosis and prioritize a number of pathways for further investigation.

2023-03-11 | GSE225336 | GEO

Biologic Mechanisms of Cancer Related Fatigue

Project description:Biologic Mechanisms of Cancer Related Fatigue

| PRJNA671344 | ENA

Childhood Atopic Asthma

Project description:Childhood Atopic Asthma

| PRJNA273399 | ENA

Systems biology of interstitial lung diseases

Project description:This SuperSeries is composed of the following subset Series: GSE21369: Gene expression profiles of interstitial lung disease (ILD) patients GSE21394: MicroRNA expression profiles of interstitial lung disease (ILD) patients Refer to individual Series

2011-04-19 | E-GEOD-21411 | biostudies-arrayexpress

Biologic Treatments in Interstitial Lung Diseases.

Project description:Interstitial lung diseases (ILD) represent a group of heterogeneous parenchymal lung disorders with complex pathophysiology, characterized by different clinical and radiological patterns, ultimately leading to pulmonary fibrosis. A considerable proportion of these disease entities present with no effective treatment, as current therapeutic regimens only slow down disease progression, thus leaving patients, at best case, with considerable functional disability. Biologic therapies have emerged and are being investigated in patients with different forms of ILD. Unfortunately, their safety profile has raised many concerns, as evidence shows that they might cause or exacerbate ILD status in a subgroup of patients. This review article aims to summarize the current state of knowledge on their role in patients with ILD and highlight future perspectives.

| S-EPMC6425869 | biostudies-literature

TEFM variants impair mitochondrial transcription elongation causing childhood-onset neurological disease

Project description:TEFM variants impair mitochondrial transcription elongation causing childhood-onset neurological disease

| PRJNA768394 | ENA

Immune Checkpoint Associated Acute Interstitial Nephritis

Project description:Tertiary lymphoid structure signatures are associated with immune checkpoint inhibitor related acute interstitial nephritis

| EGAD00010002406 | EGA